Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Nature Communications|June 3, 2020
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factorCarla Eller, Laura Heydmann, Che C Colpitts, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 29, 2025
Pre and postoperative machine learning models and point-based scores to predict risk of early recurrence in upfront resected large Hepatocellular carcinomaFabio Giannone, Thibaut Goetsch, Gianluca Cassese, et al.Journal of Hepatology|August 22, 2024
Targeting the liver clock improves fibrosis by restoring TGF-β signalingEmilie Crouchet, Mayssa Dachraoui, Frank Jühling, et al.JCI Insight|July 8, 2022
Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivationEmilie Crouchet, Shen Li, Mozhdeh Sojoodi, et al.The Journal of Clinical Investigation|September 11, 2025
Targeting peroxiredoxin 2 prevents hepatocarcinogenesis in metabolic liver disease modelsEmilie Crouchet, Eugénie Schaeffer, Marine A Oudot, et al.Egastroenterology|March 24, 2025
Protein tyrosine phosphatase delta is a STAT3-phosphatase and suppressor of metabolic liver diseaseArmando Andres Roca Suarez, Frank Jühling, Julien Moehlin, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 14, 2023
Dynamic surgical anatomy using 3D reconstruction technology in complex hepato-biliary surgery with vascular involvement. Results from an international multicentric surveyChristian Cotsoglou, Stefano Granieri, Serena Bassetto, et al.Science Translational Medicine|June 3, 2026
Claudin-1 targeting suppresses tumor growth, invasion, and metastasis in patient-derived cholangiocarcinoma modelsZeina Nehme, Marion Muller, Jade Brochon, et al.Journal of Hepatology|October 29, 2022
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironmentNatascha Roehlen, Marion Muller, Zeina Nehme, et al.Science Translational Medicine|December 21, 2022
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticityNatascha Roehlen, Antonio Saviano, Houssein El Saghire, et al.Pageof 9